£200m hospital will be built on biomedical campus which is home to covid-19 vaccine creator 

Cambridge Biomedical Campus

Source: Cambridge Biomedical Campus

A design team including Hawkins Brown and White Arkitekter has been appointed to draw up plans for the £200m Cambridge Children’s Hospital project.

Hawkins Brown was chosen for its expertise in clinical research and the UK healthcare sector, while Sweden’s White Arkitekter has global healthcare experience including recently delivering the Queen Silvia Children’s Hospital in Gothenburg.

The hospital will be built on the Cambridge biomedical campus, whose tenants currently include covid-19 vaccine creator AstraZeneca, pharma giant GlaxoSmithKline and Cancer Research UK.

It will also be home to the Cambridge Cancer Research Hospital, which was one of the 40 hospitals given funding as part of the government’s hospital building programme.

The appointment of the project design team is a major milestone in the delivery of the project, which is due to open in 2025.

The scheme is a partnership between two leading NHS trusts - Cambridge University Hospitals and Cambridgeshire and Peterborough NHS Foundation Trust - and the University of Cambridge.

The scheme aims to provide a new way of caring for young people, integrating mental and physical healthcare, alongside academic research particularly in the areas of psychology and genomics.

The team also includes Turner & Townsend, which will provide project management, design team management, stakeholder management and cost management services, engineer Ramboll and MJ Medical, which speicalises in healthcare planning.

While the health secretary committeed £100m to the project in 2018, a fundraising campaign will be announced in the spring to raise another £100m for the hospital.